DHR Stock Nears 52-Week High

Danaher stock is trading -6.81% below its average target price of $272.09 after marking a 2.0% during today's afternoon session. Analysts are giving the Large-Cap Farm & Heavy Construction Machinery company an average rating of buy and target prices ranging from $220.0 to $297.0 per share.

The stock has a very low short interest at 0.9%, and a short ratio of 2.22. The company's insiders own 10.75% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 81.7% of Danaher's shares being owned by this investor type.

Institutions Invested in Danaher

Date Reported Holder Percentage Shares Value
2024-03-31 Vanguard Group Inc 8% 60,107,030 $15,240,137,639
2024-03-31 Blackrock Inc. 7% 49,683,497 $12,597,250,815
2024-03-31 State Street Corporation 4% 27,761,136 $7,038,836,117
2024-03-31 Wellington Management Group, LLP 4% 26,724,836 $6,776,082,249
2024-03-31 FMR, LLC 3% 22,219,665 $5,633,796,128
2024-03-31 Morgan Stanley 2% 16,496,040 $4,182,570,992
2024-03-31 Price (T.Rowe) Associates Inc 2% 16,150,284 $4,094,904,557
2024-03-31 Capital International Investors 2% 15,083,818 $3,824,502,099
2024-03-31 Geode Capital Management, LLC 2% 12,913,018 $3,274,095,753
2024-03-31 JP Morgan Chase & Company 1% 10,976,945 $2,783,204,438

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Danaher.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.